Acromegaly Treatment Market

Report Highlights

The scope of this report is broad and covers different products of acromegaly treatment, along with the end-uses for acromegaly treatment, and acromegaly treatment. The market is broken down by products of acromegaly treatment, end-uses, and regional markets. Revenue forecasts from 2019 to 2025 are given for each major product of acromegaly treatment, end-use, and regional market, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional acromegaly treatment markets; it explains the major market drivers of the global acromegaly treatment industry, current trends within the industry, major end-uses, and the regional dynamics of the global acromegaly treatment market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global acromegaly treatment industry.

Report Includes

• 62 tables
• An up-to-date analysis of the global acromegaly treatment market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for global acromegaly treatment market, and corresponding market share analysis by product, end-use, and region for each market segment.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for acromegaly treatment, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of new products and products still in the development and their probability of successful commercial launch within the next five years.
• Impact of COVID-19 on the acromegaly treatment market as compared to overall global economy.
• Insight into the growth development strategies of major acromegaly treatment manufacturers and their key competitive landscape.
• Descriptive company profiles of the leading market participants, including Troikaa Pharmaceuticals Ltd., Wockhardt, VHB Life Sciences Limited, Ipsen Biopharmaceuticals Inc, GlaxoSmithKline plc, and Others.

Summary

Acromegaly is a hormonal disorder that develops in the pituitary gland that generates an excess amount of hormone during adulthood which leads to an increase in bone size, including those of hands, feet and face. Acromegaly commonly affects middle-aged adults. In children, too much growth hormone can cause a condition known as gigantism and may have excessive bone growth and abnormal growth in height.

Based on product segmentation, the market is bifurcated into Somatostatin analogs, GHRA, and Others. In 2020, the somatostatin analogs segment captured the highest share in the global market.